Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Acalabrutinib fda approval date calquence 2017?

See the DrugPatentWatch profile for Acalabrutinib

Yes. Calquence (acalabrutinib) was approved by the FDA on November 29, 2017, for adults with mantle cell lymphoma who have received at least one prior therapy.



Other Questions About Acalabrutinib :

Acalabrutinib? Is acalabrutinib safer than imbruvica? Acalabrutinib first fda approval date? Acalabrutinib maleate 100 mg tablet? Acalabrutinib fda approval october 2017 calquence? Acalabrutinib fda approval history drugs.com? Acalabrutinib fda approval date 2017 calquence?